🇺🇸 SanofiSNY

Company Update Form 6-K 01-10-2026 12:09:07 EDT

Subject: 6-K — Foreign issuer report

Overview: Expanded its alliance with Regeneron to co-develop four immunology antibodies, involving a $1 billion upfront payment and up to $7 billion in milestones.

Source: SEC EDGAR · Original filing

Open document in a new tab

Get filings like this in Telegram the moment they are published — for the companies you follow.

Start 30-day trial About Finterest